Nuclear Factor-κB1 (p50) Limits the Inflammatory and Fibrogenic Responses to Chronic Injury-Reference-Cited by-同舟云学术

Nuclear Factor-κB1 (p50) Limits the Inflammatory and Fibrogenic Responses to Chronic Injury

Published:2005-03 Issue:3 Volume:166 Page:695-708
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Oakley Fiona,Mann Jelena,Nailard Sarah,Smart David E.,Mungalsingh Narendra,Constandinou Christothea,Ali Shakir,Wilson Susan J.,Millward-Sadler Harry,Iredale John P.,Mann Derek A.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference38 articles.

1. Activators and target genes of Rel/NF-κB transcription factors;Pahl;Oncogene,1999

2. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer;Yamamoto;J Clin Invest,2001

3. NF-κB and Rel proteins: evolutionary conserved mediators of immune responses;Ghosh;Annu Rev Immunol,1998

4. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts;Gerondakis;Oncogene,1999

5. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-κB p50;Baer;Mol Cell Biol,1998

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex Dependent Disparities in the Central Innate Immune Response after Moderate Spinal Cord Contusion in Rat;Cells;2024-04-06

2. Flow-Induced Shear Stress Primes NLRP3 Inflammasome Activation in Macrophages via Piezo1;ACS Applied Materials & Interfaces;2024-01-19

3. Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1;Frontiers in Immunology;2023-08-04

4. UNVEILING THE ANTICANCER EFFECT OF SYRINGIC ACID AND ITS DERIVATIVES IN HEPATOCELLULAR CARCINOMA;International Journal of Applied Pharmaceutics;2023-07-07

5. Nuclear transcription factor kB (NF-kB) activity in lymphocyte populations in children with Wilson-Konovalov disease;Medical Immunology (Russia);2023-06-01